With VA bennies being jettisoned, customers hop on indexed annuities

Search for guaranteed income boosts sales; rising stock market fails to lift VA

May 23, 2012 @ 12:14 pm

By Darla Mercado

Annuity sales took a dive during the first quarter, but sales of fixed indexed annuities jumped — thanks in large part to guaranteed lifetime withdrawal benefit riders.

During the first three months of 2012, annuity sales fell by 8% compared to the year-earlier period, landing at $54.8 billion, according to data from LIMRA International. Variable and fixed annuities were hurt by the decline. Strengthening equity markets couldn't buoy variable annuity sales, which fell to $36.8 billion, down 7% from the comparable quarter in 2011.

Of course, insurers' decision to change their VAs to make them more conservative —read: reduced living benefits — helped squash sales.

“As we noted last quarter, we are still seeing companies carefully manage the risks associated with guaranteed living benefit riders,” said Joseph Montminy, LIMRA's assistant vice president for annuity research. “VA sales dropped despite the 13% equity market gains in the first quarter

Sales of fixed annuities, too, slipped amid a low-interest-rate environment. Sales fell 10% compared with the year-earlier period.

Indexed annuities, however, rose by 14% in the first quarter, reaching $8.1 billion.

Guaranteed lifetime withdrawal benefits helped move the product among customers: Two out of three people who bought fixed indexed annuities decided to buy a GLWB rider, which lets customers get lifetime income without annuitizing their contracts.

Allianz Life Insurance Co. of North America held onto its first place standing among sellers of fixed indexed annuities with its MasterDex X annuity. Aviva Life and Annuity Co. came in second, according to data from AnuitySpecs.com. American Equity Investment Life Holding Co. ranked third.

0
Comments

What do you think?

View comments

Recommended for you

Sponsored financial news

Featured video

INTV

Why broker-dealers are on a roll

Deputy editor Bob Hordt and senior columnist Bruce Kelly discuss last year's bounce-back for IBDs.

Latest news & opinion

Things are looking up: IBDs soared in 2017

With revenue up, interest rates rising and regulation easing, IBDs are soaring.

SEC advice rule may give RIAs leg up over broker-dealers

Experts say advisers will be able to point to their role as fiduciaries as a differentiator in the advice market.

Brokers accept proposed SEC rule on who can call themselves an adviser

Some say the rule will clear up investor confusion, but others say the SEC didn't go far enough.

SEC advice rule: Here's what you need to know

We sifted through the nearly 1,000-page proposal and picked out some of the most important points.

Cadaret Grant acquired by private-equity-backed Atria

75-year-old owner Arthur Grant positions the IBD for the 'next 33 years.'

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print